This announcement is a separate document:
上海艾力斯医药科技股份有限公司关于收到实际控制人提议实施2024年度中期分红暨落实“提质增效重回报”行动方案的公告
Announcement by Shanghai Allist Pharmaceuticals Co., Ltd. regarding receipt of proposal from actual controller to implement 2024 interim dividend distribution plan and carry out the "improving quality and efficiency, returning profits" action plan.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated